Sumitomo Mitsui Trust Holdings Inc. grew its stake in shares of Clorox Company (The) (NYSE:CLX) by 0.6% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 436,573 shares of the company’s stock after acquiring an additional 2,535 shares during the quarter. Sumitomo Mitsui Trust Holdings Inc. owned about 0.34% of Clorox Company (The) worth $57,588,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in CLX. American Beacon Advisors Inc. bought a new stake in shares of Clorox Company (The) during the 1st quarter valued at $104,000. Parkside Financial Bank & Trust lifted its position in shares of Clorox Company (The) by 3.8% during the 2nd quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock valued at $107,000 after acquiring an additional 29 shares during the period. Valley National Advisers Inc. lifted its position in shares of Clorox Company (The) by 0.6% during the 2nd quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock valued at $115,000 after acquiring an additional 5 shares during the period. Blue Chip Partners Inc. lifted its position in shares of Clorox Company (The) by 3.9% during the 2nd quarter. Blue Chip Partners Inc. now owns 941 shares of the company’s stock valued at $125,000 after acquiring an additional 35 shares during the period. Finally, Sun Life Financial INC lifted its position in shares of Clorox Company (The) by 10,344.4% during the 2nd quarter. Sun Life Financial INC now owns 940 shares of the company’s stock valued at $125,000 after acquiring an additional 931 shares during the period. Hedge funds and other institutional investors own 71.58% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This report was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another publication, it was stolen and republished in violation of United States & international copyright & trademark laws. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/11/19/sumitomo-mitsui-trust-holdings-inc-purchases-2535-shares-of-clorox-company-the-clx.html.

Shares of Clorox Company (CLX) opened at $133.51 on Friday. The company has a current ratio of 1.10, a quick ratio of 0.77 and a debt-to-equity ratio of 3.02. Clorox Company has a 1 year low of $112.28 and a 1 year high of $141.76. The firm has a market capitalization of $17,214.64, a price-to-earnings ratio of 24.06, a P/E/G ratio of 3.64 and a beta of 0.39.

Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings data on Wednesday, November 1st. The company reported $1.46 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.05. Clorox Company (The) had a return on equity of 161.59% and a net margin of 11.84%. The business had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.48 billion. During the same period in the prior year, the company earned $1.36 EPS. Clorox Company (The)’s revenue for the quarter was up 4.0% on a year-over-year basis. analysts predict that Clorox Company will post 5.58 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Wednesday, January 24th will be issued a $0.84 dividend. The ex-dividend date of this dividend is Tuesday, January 23rd. This represents a $3.36 dividend on an annualized basis and a yield of 2.52%. Clorox Company (The)’s payout ratio is presently 61.88%.

In other Clorox Company (The) news, COO Dawn C. Willoughby sold 2,158 shares of the company’s stock in a transaction dated Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total value of $297,804.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Matthew T. Laszlo sold 20,051 shares of the company’s stock in a transaction dated Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total value of $2,615,853.46. Following the completion of the transaction, the senior vice president now directly owns 10,896 shares of the company’s stock, valued at approximately $1,421,492.16. The disclosure for this sale can be found here. In the last ninety days, insiders sold 41,293 shares of company stock valued at $5,560,303. Insiders own 1.00% of the company’s stock.

A number of analysts have recently weighed in on the company. BMO Capital Markets reiterated an “outperform” rating on shares of Clorox Company (The) in a research report on Tuesday, September 12th. Jefferies Group LLC reiterated a “hold” rating and set a $137.00 target price (up from $136.00) on shares of Clorox Company (The) in a research report on Wednesday, August 9th. Barclays PLC reiterated an “equal weight” rating and set a $136.00 target price (down from $140.00) on shares of Clorox Company (The) in a research report on Friday, August 4th. BidaskClub upgraded Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research report on Monday, July 31st. Finally, Royal Bank Of Canada reiterated a “hold” rating and set a $115.00 target price on shares of Clorox Company (The) in a research report on Wednesday, August 2nd. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and three have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $128.72.

Clorox Company (The) Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.